These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1965883)

  • 1. Rapid routes of synthesis of chemically reactive and highly radioactively labeled alpha- and beta-oligonucleotide derivatives for in vivo studies.
    Boutorine AS; Le Doan T; Battioni JP; Mansuy D; Dupré D; Hélène C
    Bioconjug Chem; 1990; 1(5):350-6. PubMed ID: 1965883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-gene strategy: control of gene expression by triplex-forming-oligonucleotides.
    Hélène C
    Anticancer Drug Des; 1991 Dec; 6(6):569-84. PubMed ID: 1772570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synthesis of steroid-containing oligonucleotides and their alkylating derivatives].
    Zarytova VF; Ivanova EM; Chasovskikh MN
    Bioorg Khim; 1990 May; 16(5):610-6. PubMed ID: 2400407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid routes of synthesis of oligonucleotide conjugates from non-protected oligonucleotides and ligands possessing different nucleophilic or electrophilic functional groups.
    Grimm GN; Boutorine AS; Hélène C
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(10-12):1943-65. PubMed ID: 11200283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual isotope labeling: conjugation of 32P-oligonucleotides with 18F-aryltrifluoroborate via copper(I) catalyzed cycloaddition.
    Li Y; Schaffer P; Perrin DM
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6313-6. PubMed ID: 24144852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Internal 32P-labeling of L-deoxyoligonucleotides.
    Frauendorf C; Hausch F; Röhl I; Lichte A; Vonhoff S; Klussmann S
    Nucleic Acids Res; 2003 Apr; 31(7):e34. PubMed ID: 12655022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biophysical properties of 5'-thio-2',4'-BNA/LNA oligonucleotide.
    Islam MA; Fujisaka A; Mori S; Ito KR; Yamaguchi T; Obika S
    Bioorg Med Chem; 2018 Jul; 26(12):3634-3638. PubMed ID: 29886084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclease resistant methylphosphonate-DNA/LNA chimeric oligonucleotides.
    Nagahama K; Veedu RN; Wengel J
    Bioorg Med Chem Lett; 2009 May; 19(10):2707-9. PubMed ID: 19375912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Directing quadruplex-stabilizing drugs to the telomere: synthesis and properties of acridine-oligonucleotide conjugates.
    Casals J; Debéthune L; Alvarez K; Risitano A; Fox KR; Grandas A; Pedroso E
    Bioconjug Chem; 2006; 17(5):1351-9. PubMed ID: 16984147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the influence of stereoelectronic effects on the biophysical properties of oligonucleotides: comprehensive analysis of the RNA affinity, nuclease resistance, and crystal structure of ten 2'-O-ribonucleic acid modifications.
    Egli M; Minasov G; Tereshko V; Pallan PS; Teplova M; Inamati GB; Lesnik EA; Owens SR; Ross BS; Prakash TP; Manoharan M
    Biochemistry; 2005 Jun; 44(25):9045-57. PubMed ID: 15966728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and properties of cholesteryl-modified triple-helix forming oligonucleotides containing a triglycyl linker.
    Vu H; Hill TS; Jayaraman K
    Bioconjug Chem; 1994; 5(6):666-8. PubMed ID: 7873671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy using antisense oligodeoxynucleotides labeled with Auger-emitting radionuclides.
    Kairemo KJ; Tenhunen M; Jekunen AP
    Cancer Gene Ther; 1998; 5(6):408-12. PubMed ID: 9917096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using synthetic oligonucleotides as probes.
    Duby A; Jacobs KA; Celeste A
    Curr Protoc Mol Biol; 2001 May; Chapter 6():Unit6.4. PubMed ID: 18265259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complementary addressed alkylation of ribosomal RNA with alkylating derivatives of oligonucleotides].
    Grineva NI; Karpova GG
    Mol Biol; 1974; 8(6):832-44. PubMed ID: 4469587
    [No Abstract]   [Full Text] [Related]  

  • 15. A method for the 32P labeling of peptides or peptide nucleic acid oligomers.
    Kozlov IA; Nielsen PE; Orgel LE
    Bioconjug Chem; 1998; 9(4):415-7. PubMed ID: 9667944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syntheses of oligonucleotide derivatives with P(V) porphyrin and their properties.
    Shimidzu T; Segawa H; Kitamura M; Nimura A
    Nucleic Acids Symp Ser; 1992; (27):97-8. PubMed ID: 1289842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Design of new oligonucleotide derivatives resistant to cell nucleases].
    Gottikh MB; Ivanovskaia MG; Skripkin EA; Shabarova ZA
    Bioorg Khim; 1990 Apr; 16(4):514-23. PubMed ID: 2375779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synthesis of oligonucleotides containing an aliphatic amino group at the 5' terminus: synthesis of fluorescent DNA primers for use in DNA sequence analysis.
    Smith LM; Fung S; Hunkapiller MW; Hunkapiller TJ; Hood LE
    Nucleic Acids Res; 1985 Apr; 13(7):2399-412. PubMed ID: 4000959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HIV proliferation in MT-4 cells by antisense oligonucleotide conjugated to lipophilic groups.
    Svinarchuk FP; Konevetz DA; Pliasunova OA; Pokrovsky AG; Vlassov VV
    Biochimie; 1993; 75(1-2):49-54. PubMed ID: 8504177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of β-pyrrolic-modified porphyrins and their incorporation into DNA.
    Stephenson AW; Partridge AC; Filichev VV
    Chemistry; 2011 May; 17(22):6227-38. PubMed ID: 21503985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.